Manuela Zlamy

Manuela Zlamy

Auto-generated profile, based on publicly available information

Manuela Zlamy

Department of Pediatrics, Clinic I Medical University of Innsbruck Innsbruck Austria

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MZManuela Zlamy
Manuela Zlamy
SKSabine Kofler
Sabine Kofler
DODorothea Orth-Höller
Dorothea Orth-Höller
RWReinhard Würzner
Reinhard Würzner
PHPeter Heinz-Erian
Peter Heinz-Erian
MPMartina Prelog
Martina Prelog
Background: The aim of the study was to evaluate the effects of universal mass vaccination (UMV) against rotavirus (RV) on the hospitalization rates, nosocomial RV infections and RV-gastroenteritis (GE)-associated secondary blood stream infections (BSI). Methods: The retrospective evaluation (2002–2009) by chart analysis included all clinically diagnosed and microbiologically confirmed RV-GE cases in a large tertiary care hospital in Austria. The pre-vaccination period (2002–2005) was compared with the recommended and early funded (2006–2007) and the funded (2008–2009) vaccination periods. Primary outcomes were RV-GE-associated hospitalizations, secondary outcomes nosocomial RV disease, secondary BSI and direct hospitalization costs for children and their accompanying persons. Results: In 1,532 children with RV-GE, a significant reduction by 73.9% of hospitalized RV-GE cases per year could be observed between the pre-vaccination and the funded vaccination period, which was most pronounced in the age groups 0–11 months (by 87.8%), 6–10 years (by 84.2%) and 11–18 years (88.9%). In the funded vaccination period, a reduction by 71.9% of nosocomial RV-GE cases per year was found compared to the pre-vaccination period. Fatalities due to nosocomial RV-GE were only observed in the pre-vaccination period (3 cases). Direct costs of hospitalized, community-acquired RV-GE cases per year were reduced by 72.7% in the funded vaccination period. The reduction of direct costs for patients (by 86.9%) and accompanying persons (86.2%) was most pronounced in the age group 0–11 months. Conclusions: UMV may have contributed to the significant decrease of RV-GE-associated hospitalizations, to a reduction in nosocomial RV infections and RV-associated morbidity due to secondary BSI and reduced direct hospitalization costs. The reduction in nosocomial cases is an important aspect considering severe disease courses in hospitalized patients with co-morbidities and death due to nosocomial RV-GE.

2 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMiriam Michel
Miriam Michel
KDKarl-Otto Dubowy
Karl-Otto Dubowy
AEAndreas Entenmann
Andreas Entenmann
DKDaniela Karall
Daniela Karall
MAMark Gordian Adam
Mark Gordian Adam
SSSabine Scholl-Bürgi
Sabine Scholl-Bürgi
Growing interest lies in the assessment of the metabolic status of patients with a univentricular circulation after Fontan operation, especially in changes of amino acid metabolism. Using targeted metabolomic examinations, we investigated amino acid metabolism in a homogeneous adult Fontan-patient group with a dominant left ventricle, seeking biomarker patterns that might permit better understanding of Fontan pathophysiology and early detection of subtle ventricular or circulatory dysfunction. We compared serum amino acid levels (42 analytes; AbsoluteIDQ p180 kit, Biocrates Life Sciences, Innsbruck, Austria) in 20 adult Fontan patients with a dominant left ventricle and those in age- and sex-matched biventricular controls. Serum concentrations of asymmetric dimethylarginine, methionine sulfoxide, glutamic acid, and trans-4-hydroxyproline and the methionine sulfoxide/methionine ratio (Met-SO/Met) were significantly higher and serum concentrations of asparagine, histidine, taurine, and threonine were significantly lower in patients than in controls. Met-SO/Met values exhibited a significant negative correlation with oxygen uptake during exercise. The alterations in amino acid metabolome that we found in Fontan patients suggest links between Fontan pathophysiology, altered cell energy metabolism, oxidative stress, and endothelial dysfunction like those found in biventricular patients with congestive heart failure. Studies of extended amino acid metabolism may allow better understanding of Fontan pathophysiology that will permit early detection of subtle ventricular or circulatory dysfunction in Fontan patients.

8 June 2016 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
MZManuela Zlamy
Manuela Zlamy
Pertussis, caused by Bordetella (B.) pertussis, a Gram-negative bacterium, is a highly contagious airway infection. Especially in infants pertussis remains a major health concern. Acute infection with B. pertussis can cause severe illness characterized by severe respiratory failure, pulmonary hypertension, leucocytosis and death. Over the last years rising incidence rates of intensive care treatment in young infants were described. Due to several virulence factors (pertussis toxin, tracheal cytotoxin, adenylate cyclase toxin, filamentous hemagglutinin, lipooligosaccharide) which promote bacterial adhesion and invasion B. pertussis creates a unique niche for colonization within the human respiratory tract. The resulting long-term infection is mainly caused by the ability of B. pertussis to interfere with the host’s innate and adaptive immune system. Although pertussis is a vaccine-preventable disease it has persisted in vaccinated populations. Epidemiological data reported a worldwide increase in pertussis incidence among children during the last years. Either acellular pertussis vaccines or whole-cell vaccines are worldwide used. Recent studies did not detect any differences according pertussis incidence comparing the different vaccines used. Most of the currently used acellular pertussis vaccines protect against acute infections for a period of 6-8 years. The resurgence of pertussis may be due to the lack of herd immunity caused by missing booster immunizations among adolescents and adults, low vaccine coverages in some geographic areas and genetic changes of different B. pertussis strains. Due to the rising incidence of pertussis probable solution strategies are discussed. Cocooning strategies (vaccination of close contact persons) and immunizations during pregnancy appear to be an approach to reduce neonatal contagiousness. During the last years studies focused on the pathway of the immune modulation done by B. pertussis to provide a basis for the identification of new therapeutic targets to enhance the host’s immune response and to probable modulate certain virulence factors.

6 November 2015 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
MZManuela Zlamy
Manuela Zlamy
EHEdda Haberlandt
Edda Haberlandt
JBJürgen Brunner
Jürgen Brunner
LDLudwig Dozcy
Ludwig Dozcy
KRKevin Rostasy
Kevin Rostasy

15 December 2020 in Metabolomics
Verified
Journal Article
Open access
PDF file
MMMiriam Michel
Miriam Michel
CSChristina Salvador
Christina Salvador
VWVerena Wiedemair
Verena Wiedemair
MAM Gordian Adam
M Gordian Adam
KLKai Thorsten Laser
Kai Thorsten Laser
SSSabine Scholl-Buergi
Sabine Scholl-Buergi
Introduction: Metabolomics studies are not routine when quantifying amino acids (AA) in congenital heart disease (CHD).Objectives: Comparative analysis of 24 AA in serum by traditional high-performance liquid chromatography (HPLC) based on ion exchange and ninhydrin derivatisation followed by photometry (PM) with ultra-high-performance liquid chromatography and phenylisothiocyanate derivatisation followed by tandem mass spectrometry (TMS); interpretation of findings in CHD patients and controls.Methods: PM: Sample analysis as above (total run time, ~ 119 min).TMS: Sample analysis by AbsoluteIDQ® p180 kit assay (BIOCRATES Life Sciences AG, Innsbruck, Austria), which employs PITC derivatisation; separation of analytes on a Waters Acquity UHPLC BEH18 C18 reversed-phase column, using water and acetonitrile with 0.1% formic acid as the mobile phases; and quantification on a Triple-Stage Quadrupole tandem mass spectrometer (Thermo Fisher Scientific, Waltham, MA) with electrospray ionisation in the presence of internal standards (total run time, ~ 8 min). Calculation of coefficients of variation (CV) (for precision), intra- and interday accuracies, limits of detection (LOD), limits of quantification (LOQ), and mean concentrations.Results: Both methods yielded acceptable results with regard to precision (CV < 10%PM, < 20%TMS), accuracies (< 10%PM, < 34%TMS), LOD, and LOQ. For both Fontan patients and controls AA concentrations differed significantly between methods, but patterns yielded overall were parallel.Conclusion: Serum AA concentrations differ with analytical methods but both methods are suitable for AA pattern recognition.TMS is a time-saving alternative to traditionalPMunder physiological conditions as well as in patients with CHD.Trial registration number: ClinicalTrials.gov Identifier NCT03886935, date of registration March 27th, 2019 (retrospectively registered).

25 March 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
MZManuela Zlamy
Manuela Zlamy
TZThomas Zöggeler
Thomas Zöggeler
MBMagdalena Bachmann
Magdalena Bachmann
MSMichael Schirmer
Michael Schirmer
CLChristian Lechner
Christian Lechner
SSSabine Scholl-Bürgi
Sabine Scholl-Bürgi
Earlier studies have recommended routine childhood immunization in patients with propionic acidemia (PA); however, the literature presents insufficient data on the response to vaccines, notably specific IgG concentrations and avidity maturation, after measles, mumps, rubella (MMR), and diphtheria/tetanus (DiphtTe) vaccinations in this population. In patients with PA, cellular and humoral changes of the immune system (e.g. a decreased CD4+ T cell count, with a reversal of CD4/CD8 T cell ratio, a deficient gamma-globulin fraction, and in one case a decreased lymphocyte blastogenesis) have been reported. Former reports also detected pancytopenias accompanying febrile infections in PA patients. In the current study, we analyzed vaccine-specific IgG concentrations and avidity maturation after MMR and DiphtTe vaccinations in 10 patients with PA. Compared to gender and age matched controls, all 10 had protective IgG concentrations for at least one tested antigen, and in 6 out of 10 patients high relative avidity indices for measles and rubella were detected. In summary, the present study revealed a sufficient immune response and outcome, indicating an acceptable humoral memory in patients with PA after booster vaccinations.